Marissa Brittenham, Chief Strategy Officer at Surgery Partners, Inc. (SGRY), sold 14,700 shares at $25.61 ($376K) on 2025-02-07, disclosed to the SEC on 2025-02-10.
Seasonal sale ($376k) by Chief Strategy Officer — this insider has traded SGRY in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SGRY | SELL | 2025-03-13 | $152K | — | Filing → |
| SGRY | SELL | 2024-03-06 | $39K | — | Filing → |
| SGRY | SELL | 2024-02-06 | $104K | — | Filing → |